We are live on ! Find out more
VKTXW

Viking Therapeutics, Inc.
VKTXW

Delisted

VKTXW was delisted on the 8th of April, 2021.

Back to rankings

3 hedge funds and large institutions have $169K invested in Viking Therapeutics, Inc. in 2017 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

50% more funds holding

Funds holding: 2 → 3 (+1)

3% less capital invested

Capital invested by funds: $175K → $169K (-$6K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
3
Holders Change
+1
Holders Change %
+50%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
1
Closed
1
Calls
$92K
Puts
–
Net Calls
+$92K
Net Calls Change
+$9K

Top Buyers

1
PWAM
Park West Asset Management
California
+$22K
2
UBS Group
UBS Group
Switzerland
+$97

Top Sellers

1
SM
Sabby Management
Florida
-$39K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$6.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$143K -$6.7K -16,000 -5%
PWAM
2
Park West Asset Management
California
$26K +$22K +52,500 New
SM
3
Sabby Management
Florida
– -$39K -86,349 Closed
UBS Group
4
UBS Group
Switzerland
– +$97 +232 New

VKTXW Hedge Fund Activity: Q1 2017 in Review

3 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics, Inc. (VKTXW) for Q1 2017, worth a combined $169K — down 3.4% from $175K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new VKTXW positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Park West Asset Management, opening a new position worth an estimated $22K. The largest seller was Sabby Management, exiting entirely with an estimated $39K sold.

  • 3 institutional investors held Viking Therapeutics, Inc. (VKTXW) as of Q1 2017, up from 2 in Q4 2016.
  • Funds reported $169K of Viking Therapeutics, Inc. stock for Q1 2017, down 3.4% quarter-over-quarter.
  • 2 funds opened new Viking Therapeutics, Inc. positions in Q1 2017 and 1 closed out, a net change of +1 holder.
  • The largest Viking Therapeutics, Inc. buyer in Q1 2017 was Park West Asset Management, an estimated $22K added.
  • The largest Viking Therapeutics, Inc. seller in Q1 2017 was Sabby Management, an estimated $39K sold.

Based on aggregated 13F filings for Q1 2017.